Advertisement

Epidemiology and Ecology of Pityriasis Versicolor

  • Jan Faergemann
Part of the Current Topics in Medical Mycology book series (CT MYCOLOGY, volume 3)

Abstract

Pityriasis versicolor is a chronic superficial fungal disease. It is usually localized on the upper part of the chest or on the back, neck, or upper arms. Lesions may be red, brown, or white. They are often slightly scaling, papular, or nummular, or they may coalesce to involve larger areas of the body. The conidia and short hyphae of the lipophilic yeast Malassezia furfur (syn. Pityrosporum orbiculare) can be detected by microscopy.

Keywords

Atopic Dermatitis Seborrheic Dermatitis Pityriasis Versicolor Human Stratum Corneum Tinea Versicolor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Albright SD, Hitch JM: Rapid treatment of tinea versicolor with selenium sulfide. Arch Dermatol 93: 460, 1966.PubMedCrossRefGoogle Scholar
  2. 2.
    Alexander S: Loss of hair and dandruff. Br J Dermatol 79: 549–552, 1968.CrossRefGoogle Scholar
  3. 3.
    Bäck O, Faergemann J, Hørnqvist R: Pityrosporum folliculitis: a common disease of the young and middle aged. J Am Acad Dermatol 12: 56–61, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Breathnach, AS Nazzaro-porro M, Martin B: Ultrastructure of the skin in pityriasis versicolor. Minerva Dermatol 10: 475–469, 1975.Google Scholar
  5. 5.
    Brinkman A: Zum Vorkommen von Dermatomykosen in Liberia. Tropenmed Parasitol 25: 350–359, 1974.PubMedGoogle Scholar
  6. 6.
    Burke RC: Tinea versicolor: susceptibility factors and experimental infections in human beings. J Invest Dermatol 36: 389–402, 1961.PubMedGoogle Scholar
  7. 7.
    Caprilli F, Mercantini R, Nazzaro-Porro M, Passi S, Tonolo A: Studies of the genus Pityrosporum in submerged culture. Mycopathol My col Appl 5: 171–189, 1973.CrossRefGoogle Scholar
  8. 8.
    Caprilli F, Nazzaro-Porro M, Passi S: Pityriasis versicolore. Stud Clin Bull Inst Dermatol 7: 71–89, 1971.Google Scholar
  9. 9.
    Castellani A, Chalmers AJ: Manual of Tropical Medicine. Ballieré, Tindall and Cox, London, 1913.Google Scholar
  10. 10.
    Drouhet E, Dompmartin D, Papachristou-Moraiti, Ravissi P: Dermatite expérimentale a Pityrosporum ovale et (ou) Pityrosporum orbiculare chez le cobaye et la souris. Sabouraudia 18: 149–156, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    Faergemann J: Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages. J Invest Dermatol 89: 133–135, 1983.CrossRefGoogle Scholar
  12. 12.
    Faergemann J: Lipophilic yeasts in skin disease. Sem Dermatol 4: 173–184, 1985.Google Scholar
  13. 13.
    Faergemann J: Pityriasis versicolor (tinea versicolor). Clin Dermatol 3: 17–20, 1986.Google Scholar
  14. 14.
    Faergemann J: Quantitative culture of Pityrosporum orbiculare. IntJ Dermatol 23: 110–111, 1984.CrossRefGoogle Scholar
  15. 15.
    Faergemann J: Seborrheic dermatitis and Pityrosporum orbiculare: treatment of seborrheic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 114: 695–700, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Faergemann J: The use of contact plates for quantitative culture of Pityrosporum orbiculare. Mykosen 30: 298–304, 1987.PubMedGoogle Scholar
  17. 17.
    Faergemann J: Treatment of sebopsoriasis with itraconazole. Mykosen 28: 612–618, 1985.PubMedGoogle Scholar
  18. 18.
    Faergemann J, Aly R, Maibach HI: Growth and filament production of Pityrosporum orbiculare and P. ovale on human stratum corneum in vitro. Acta Dermatol Venereol (Stockh) 63: 388–392, 1983.Google Scholar
  19. 19.
    Faergemann J, Aly R, Maibach HI: Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin. Acta Dermatol Venereol (Stockh) 63: 346–348, 1983.Google Scholar
  20. 20.
    Faergemann J, Bernander S: Micro-aerophilic and anaerobic growth of Pityrosporum orbiculare. Sabouraudia 19: 117–121, 1981.PubMedCrossRefGoogle Scholar
  21. 21.
    Faergemann J, Bernander S: Tinea versicolor and Pityrosporum orbiculare: a mycological investigation. Sabouraudia 17: 171–179, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Faergemann J, Djärv L: Tinea versicolor; treatment and prophylaxis with ketoconazole. Cutis 30: 542–545, 1982.PubMedGoogle Scholar
  23. 23.
    Faergemann J, Fredriksson T: Age incidence of Pityrosporum orbiculare on human skin. Acta Dermatol Venereol (Stockh) 60: 531–533, 1980.Google Scholar
  24. 24.
    Faergemann J, Fredriksson T: An open trial of the effect of a zinc pyrithione shampoo in tinea versicolor. Cutis 25: 667–669, 1980.PubMedGoogle Scholar
  25. 25.
    Faergemann J, Fredriksson T: Experimental infections in rabbits and humans with Pityrosporum orbiculare and P. ovale. J Invest Dermatol 77: 314–318, 1981.PubMedCrossRefGoogle Scholar
  26. 26.
    Faergemann J, Fredriksson T: Propylene glycol in the treatment of tinea versicolor. Acta Dermatol Venereol (Stockh) 60: 92–93, 1980.Google Scholar
  27. 27.
    Faergemann J, Frederiksson T: Tinea versicolor with regard to seborrheic dermatitis. Arch Dermatol 115: 966–968, 1979.PubMedCrossRefGoogle Scholar
  28. 28.
    Faergemann J, Fredriksson T, Nathorst-Windahl G: One case of confluent and reticulate papillomatosis (Gougerot-Catreaud). Acta Dermatol Venereol (Stockh) 60: 269–271, 1980.Google Scholar
  29. 29.
    Faergemann J, Tjernlund U, Scheynius A, Bernander S: Antigenic similarities and differences in genus Pityrosporum. J Invest Dermatol 78: 28–31, 1982.PubMedCrossRefGoogle Scholar
  30. 30.
    Ford GP, Ive FA Midgley G: Pityrosporum folliculitis and ketaconazole. Br J Dermatol 107: 691–695, 1982.PubMedCrossRefGoogle Scholar
  31. 31.
    Fredriksson T: Topical treatment with BAY b 5097, a new broad spectrum antimycotic agent. Br J Dermatol 86: 628, 1972.PubMedCrossRefGoogle Scholar
  32. 32.
    Gonzalea-Ochoa A: Pityriasis versicolor. Rev Med 2: 81–88, 1956.Google Scholar
  33. 33.
    Gordon MA: Lipophilic yeast-like organisms associated with tinea versicolor. J Invest Dermatol 17: 267–272, 1951.PubMedGoogle Scholar
  34. 34.
    Gordon MA: The lipophylic mycoflora of the skin. Mycologia 43: 524–534, 1951.CrossRefGoogle Scholar
  35. 35.
    Gougerot H, Carteaud A: Papillomatose pigmentée incompinée. Bull Soc Fr Dermatol Syph 34: 719, 1927.Google Scholar
  36. 36.
    Hafez M, El-Shamy S: genetic susceptibility in pityriasis versicolor. Dermatologica 171: 86–88, 1985.PubMedCrossRefGoogle Scholar
  37. 37.
    Hay RJ Midgeley G: Short course ketaconazole therapy in pityriasis versicolor. Clin Exp Dermatol 9: 571–573, 1984.PubMedCrossRefGoogle Scholar
  38. 38.
    Hjorth N, Clemmensen OJ: Treatment of dermatitis of the head and neck with ketaconazole in patients with type I hypersensitivity for Pityrosporum orbiculare. Sem Dermatol 2: 26–29, 1983.Google Scholar
  39. 39.
    Jones HE: Ketoconazole Today: A Review of Clinical Experience. Adis Press, Manchester, 1987.Google Scholar
  40. 40.
    Malassez L: Note sur le champignon du pityriasis simplex. Arch Physiol Norm Pathol (Series 2 ) 1: 451–464, 1874.Google Scholar
  41. 41.
    Marples MJ: The incidence of certain skin diseases in western Samoa: a preliminary survey. Trans R Soc Trop Med Hyg 44: 319–332, 1950.PubMedCrossRefGoogle Scholar
  42. 42.
    Nazzaro-Porro M, Passi S: Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 71: 205–208, 1978.PubMedCrossRefGoogle Scholar
  43. 43.
    Nazzaro-Porro M, Passi S, Caprilli F, Mercantini R: Induction of hyphae in cultures in Pityrosporum by cholesterol and cholesterol esters. J Invest Dermatol 69: 531–534, 1977.CrossRefGoogle Scholar
  44. 44.
    Oberle AD, Fowler M, Grafton WD: Pityrosporum isolate from the upper respiratory tract. Am Soc Clin Pathol 76: 112–116, 1981.Google Scholar
  45. 45.
    Porro MN Passi S, Caprilli F, Nazzaro P, Morpurgo G: Growth requirements and lipid metabolism of Pityrosporum orbiculare. J Invest Dermatol 36: 389–402, 1961.Google Scholar
  46. 46.
    Prober CG, Ein SH: Systemic tinea versicolor or how far can M. furfur go? Excerpta Med 3: 592, 1984.Google Scholar
  47. 47.
    Randjadiche M: Polymorphisme de Pityrosporum ovale (Bizzozero) Castellani and Castellani & Chalmers in vitro et in vivo. Bull Soc Med 5: 79–84, 1976.Google Scholar
  48. 48.
    Rausch LJ, Jacobs PH: Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. Cutis 34: 470–471, 1984.PubMedGoogle Scholar
  49. 49.
    Redline RW, Bagnali H, Glen D, Averiii S: Malassezia pulmonary vasculitis in an infant on long-term Intralipid therapy. Lancet 2: 956, 1979.Google Scholar
  50. 50.
    Rivolta S: Parassiti Vegetali. Torinpo, Italy, 1873.Google Scholar
  51. 51.
    Roberts SOB: Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol 81: 314–326, 1969.CrossRefGoogle Scholar
  52. 52.
    Roberts SOB: Pityrosporum orbiculare: incidence and distribution on clinically normal skin. Br J Dermatol 81: 264–269, 1969.PubMedCrossRefGoogle Scholar
  53. 53.
    Roberts SOB, Lachapelle JM: Confluent and reticulate papillomatosis (Gougerot-Carteaud) and Pityrosporum orbiculare. Br J Dermatol 81: 841–843, 1969.PubMedCrossRefGoogle Scholar
  54. 54.
    Robin C: Historie Naturelle des Végétaux Parasites. Bailliére, London, p. 438, 1853.Google Scholar
  55. 55.
    Rosenberg EW, Belew PW, Skinner RB: Treatment of psoriasis with antimicrobial agents, in Roenigk H, Maibach HI (eds) Psoriasis. Marcel Dekker, New York, 1985.Google Scholar
  56. 56.
    Salkin IF, Gordon MA: Polymorphism of Malassezia furfur. Can J Microbiol 23: 471–475, 1977.PubMedCrossRefGoogle Scholar
  57. 57.
    Savin RC, Horwitz SN: Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol 15: 500–503, 1986.PubMedCrossRefGoogle Scholar
  58. 58.
    Schwarz KJ, Much TH, Kenzelmann M: Poliklinische Prüfung von Econazole bei 594 Fällen von Hautmykosen. Dtsch Med Wochenschr 100: 1497–1500, 1975.PubMedCrossRefGoogle Scholar
  59. 59.
    Shuster S: The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 111: 235–242, 1984.PubMedCrossRefGoogle Scholar
  60. 60.
    Sloof WC: Genus Pityrosporum. “Sabouraud,” in Lobber J (ed) The Yeasts (2nd ed). North Holland, Amsterdam, pp 1167–1970, 1971.Google Scholar
  61. 61.
    Sohnle PG, Collins-Lech C: Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients with tinea versicolor. Clin Exp Immunol 49: 559–564, 1982.PubMedGoogle Scholar
  62. 62.
    Sohnle PG, Collins-Lech C: Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients with tinea versicolor. J Clin Invest 62: 45–53, 1978.PubMedCrossRefGoogle Scholar
  63. 63.
    Svejgaard E: Double-blind trial of miconazole in dermatomycosis. Acta Dermatol Venereol (Stockh) 53: 497–499, 1973.Google Scholar
  64. 64.
    Wallace M, Bagnali H, Glen D, Averiii S: Isolation of lipophilic yeast in “sterile” peritonitis. Lancet 2: 956, 1979.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • Jan Faergemann

There are no affiliations available

Personalised recommendations